Francesco Berlanda Scorza
机构: GSK Vaccines Institute for Global Health (GVGH)
主页: linkedin.com
每年引用次数
引用次数
引用: 2,446
H-指数: 21
I10-指数 : 30
出版物: 75
Chimeric Hemagglutinin-Based Live-Attenuated Vaccines Confer Durable Protective Immunity against Influenza A Viruses in a Preclinical Ferret Model.
Wen-Chun Liu , Raffael Nachbagauer , Daniel Stadlbauer , Shirin Strohmeier
Vaccine 9 ( 1) 40
1
2021
Sequential Immunization With Live-Attenuated Chimeric Hemagglutinin-Based Vaccines Confers Heterosubtypic Immunity Against Influenza A Viruses in a Preclinical Ferret Model.
Wen-Chun Liu , Raffael Nachbagauer , Daniel Stadlbauer , Alicia Solórzano
Frontiers in Immunology 10 756
29
2019
A universal influenza virus vaccine candidate confers protection against pandemic H1N1 infection in preclinical ferret studies
Raffael Nachbagauer , Wen-Chun Liu , Angela Choi , Teddy John Wohlbold
NPJ vaccines 2 ( 1) 26
76
2017
Immunogenicity of chimeric haemagglutinin-based, universal influenza virus vaccine candidates: interim results of a randomised, placebo-controlled, phase 1 clinical trial
David I Bernstein , Jeffrey Guptill , Abdollah Naficy , Raffael Nachbagauer
Lancet Infectious Diseases 20 ( 1) 80 -91
46
2020
A chimeric haemagglutinin-based universal influenza virus vaccine boosts human cellular immune responses directed towards the conserved haemagglutinin stalk domain and the viral nucleoprotein
Carly M Bliss , Raffael Nachbagauer , Chiara Mariottini , Frans Cuevas
EBioMedicine 104
1
2024
A chimeric hemagglutinin-based universal influenza virus vaccine approach induces broad and long-lasting immunity in a randomized, placebo-controlled phase I trial.
Raffael Nachbagauer , Jodi Feser , Abdollah Naficy , David I Bernstein
Nature Medicine 27 ( 1) 106 -114
162
2021
Rna purification methods
Francesco Berlanda Scorza , Andrew Geall , Frederick Porter , Yingxia Wen
17
2014
Immunogens from uropathogenic escherichia coli
Mariagrazia Pizza , Laura Serino , Francesco Berlanda Scorza , Vega Masignani
44
2006
Proteins and nucleic acids from meningitis/sepsis-associated escherichia coli
Mariagrazia Pizza , Laura Serino , Vega Masignani , Francesco Berlanda Scorza
85
2006
Prophylaxis and Treatment against Klebsiella pneumoniae: Current Insights on This Emerging Anti-Microbial Resistant Global Threat.
Francesca Micoli , Gianmarco Gasperini , Vanessa Arato , Maria Michelina Raso
International Journal of Molecular Sciences 22 ( 8) 4042
23
2021
Safety and immunogenicity of a seasonal trivalent inactivated split influenza vaccine: a phase I randomized clinical trial in healthy Serbian adults.
Goran Stevanovic , Lidija Lavadinovic , Svetlana Filipovic Vignjevic , Renée Holt
Human Vaccines & Immunotherapeutics 14 ( 3) 579 -586
3
2018
Advancing new vaccines against pandemic influenza in low-resource countries.
Francesco Berlanda Scorza
Vaccine 35 ( 40) 5397 -5402
6
2017
Immunogenicity and efficacy of the monovalent, trivalent and quadrivalent intranasal live attenuated influenza vaccines containing different pdmH1N1 strains.
Leena R. Yeolekar , Milan Ganguly , Parikshit Tyagi , Nilesh B. Ingle
Vaccine 36 ( 46) 6944 -6952
6
2018
Convening on the influenza human viral challenge model for universal influenza vaccines, Part 2: Methodologic considerations.
Bruce L. Innis , Francesco Berlanda Scorza , Jeremy S. Blum , Varsha K. Jain
Vaccine 37 ( 35) 4830 -4834
6
2019
Meeting report: Convening on the influenza human viral challenge model for universal influenza vaccines, Part 1: Value; challenge virus selection; regulatory, industry and ethical considerations; increasing standardization, access and capacity.
Bruce L. Innis , Francesco Berlanda Scorza , Jeremy S. Blum , Varsha K. Jain
Vaccine 37 ( 35) 4823 -4829
7
2019
A Novel Phase Variation Mechanism in the Meningococcus Driven by a Ligand-Responsive Repressor and Differential Spacing of Distal Promoter Elements
Matteo M. E. Metruccio , Eva Pigozzi , Davide Roncarati , Francesco Berlanda Scorza
PLoS Pathogens 5 ( 12) e1000710
74
2009
A Phase 2/3 double blinded, randomized, placebo-controlled study in healthy adult participants in Vietnam to examine the safety and immunogenicity of an inactivated whole virion, alum adjuvanted, A(H5N1) influenza vaccine (IVACFLU-A/H5N1).
Tran Nhu Duong , Vu Dinh Thiem , Dang Duc Anh , Nguyen Phu Cuong
Vaccine 38 ( 6) 1541 -1550
1
2020
Digital Droplet PCR for Influenza Vaccine Development
Alexander J. Veach , Clayton Beard , Frederick Porter , Mark Wilson
Procedia in Vaccinology 9 96 -103
2
2015
Universal influenza vaccines: Shifting to better vaccines.
Francesco Berlanda Scorza , Vadim Tsvetnitsky , John J. Donnelly
Vaccine 34 ( 26) 2926 -2933
85
2016
Chemistry, manufacturing and control (CMC) and clinical trial technical support for influenza vaccine manufacturers.
Rahnuma Wahid , Renee Holt , Richard Hjorth , Francesco Berlanda Scorza
Vaccine 34 ( 45) 5430 -5435
6
2016